The Neutrophil-to-Monocyte Ratio and Platelet-to-White Blood Cell Ratio Represent Novel Prognostic Markers in Patients with Pancreatic Cancer

Table 1

Clinicopathologic characteristics.

Variables	(%)	/median (Q1–Q3)
Age (years)
<65	105 (39.0%)
≥65	164 (61.0%)
Gender
Male	155 (57.6%)
Female	114 (42.4%)
TNM stages
I-III	45 (16.7%)
IV	224 (83.3%)
Median survival time (months)		2.0 (1.0~4.0)
Survival outcomes
Death	260 (96.7%)
Survival	9 (3.3%)